Clinical trial
SMAD4 Methylation and Expression Levels in Non-melanocytic Skin Cancers; SMAD4 Protein Positivity
NCT04759261 is registered in ClinicalTrials.gov with Trakya University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SMAD4 Methylation and Expression Levels in Non-melanocytic Skin Cancers; SMAD4 Protein Positivity
- Lead sponsor
- Trakya University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- December 1, 2020
- Completion date
- December 31, 2022
- Enrollment
- 75 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.